Evidence map›Paper›PMID 19060758›Full record

ArticleJournal of burn care & research : official publication of the American Burn Association

Propranolol restores the tumor necrosis factor-alpha response of circulating inflammatory monocytes and granulocytes after burn injury and sepsis.

Kuzhali Muthu, Li-Ke He, Andrea Szilagyi, Julia Stevenson, Richard L Gamelli, Ravi Shankar

Open access · greenAbstract read
In one paragraph

Article in Journal of burn care & research : official publication of the American Burn Association. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Animal models in burn research.Cellular and molecular life sciences : CMLS · 2014
    Review
  7. Review
  8. Retinol binding protein: marker for insulin resistance and inflammation postburn?JPEN. Journal of parenteral and enteral nutrition · 2011
    Article
  9. Article
  10. Morphological Changes in Subcutaneous White Adipose Tissue After Severe Burn Injury.Journal of burn care & research : official publication of the American Burn Association
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Kuzhali MuthuDepartment of Surgery, Burn & Shock Trauma Institute, Loyola University Medical Center, Maywood, Illinois, USA.
Li-Ke He
Andrea Szilagyi
Julia Stevenson
Richard L Gamelli
Ravi Shankar
Loyola University Medical Center · US

Funding

MYELOPOIETIC STIMULATION FOLLOWING BURN INJURYR01GM042577 · NIGMS · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI GAMELLI, RICHARD LOUIS · 1989 to 2007
$2.1M
Adrenergic Control of Stem Cell Lineage Commitment in SepsisR03AI079530 · NIAID · LOYOLA UNIVERSITY CHICAGO · PI MUTHUMALAIAPPAN, KUZHALI · 2008 to 2009
$149k
NIAID NIH HHS R03 AI079530NIGMS NIH HHS R01 GM042577NIGMS NIH HHS R01 GM 42577
6 · The paper itself

Abstract

Beta-adrenergic blockade ameliorates the hypermetabolism and catabolism in severe burn injury. Despite the salutary effects of beta-adrenergic blockade, the immunologic responses that accompany beta-blockade are not known. We have shown that burn sepsis is associated with increased sympathetic activation leading to altered monocytopoiesis and cytokine release in macrophages (MØ). Recent evidence suggests that murine MØ expressing F4/80+Gr1+ are the inflammatory phenotype. Here, we report that propranolol given after burn sepsis modulates the number and function of myeloid cells in circulation. B6D2F1 male mice were divided into sham (S), burn (B), and burn sepsis (BS) groups. Dorsal hair was shaved from S, B, and BS; B and BS received 15% scald burn; BS was inoculated with Pseudomonas Aeruginosa (PA 14, 4000-5000 colony-forming units) at the burn site. Mice from each group were then subjected to two different treatment regimens. One set received subcutaneous injections of propranolol (5 mg/kg body weight) at 24 and 48 hours after the injury while the control groups received saline. Blood was collected by cardiac puncture at 72 hours. The distribution of total F4/80+ monocyte population was determined by flow cytometry. Inflammatory monocyte subset was gated on Gr1+ expression in the F4/80+ fraction. Lipopolysaccharide-stimulated intracellular tumor necrosis factor (TNF)-alpha (ic-TNF) was also measured as an indicator of inflammatory response. The total F4/80+ monocyte fraction was significantly increased in BS (45 +/- 0.8%) vs S and B (10 +/- 0.8%; 9.5 +/- 0.6%). Propranolol treatment for 2 days reduced the number of circulating monocytes by 60% in BS. The mean fluorescent intensity (MFI) of ic-TNF produced per cell (F4/80+Gr1+ MØ) was significantly decreased in B and BS (S: 3043 +/- 213, B: 1638 +/- 343, BS: 1463 +/- 67). Of importance, propranolol treatment partially restored the MFI of ic-TNF (2177 +/- 114) and increased the percentage of inflammatory monocyte subset (F4/80+Gr1+) in BS by 70% compared with saline treatment. In contrast, beta-blockade after BS increased the percentage of granulocytes in circulation (28.4 +/- 3.6% in BS propranolol vs 15.4 +/- 0.3% in BS saline; P < .05) and augmented their TNF production (MFI = 903 +/- 102 in BS propranolol vs 644 +/- 5 in BS saline; P < .05). Propranolol reverses burn sepsis-induced monocytosis and simultaneously increases the number of granulocytes and enhances the inflammatory potential of the granulocytes and inflammatory monocyte subsets in circulation suggesting that monitoring MØ subsets and granulocytes in blood is a reliable biomarker to predict the efficacy of beta-blockade.

Indexed as

AnimalsBurnsDisease Models, AnimalEnzyme-Linked Immunosorbent AssayGranulocytesInflammationInterleukin-6MaleMiceMonocytesPropranololSepsisTumor Necrosis Factor-alphaInterleukin-6PropranololTumor Necrosis Factor-alpha

Identifiers

PMID19060758
PMCPMC2718759
OpenAlexW2409616269

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.